Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2026-02-18
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the safety and tolerability of AMG 160 and to evaluate the
maximum tolerated dose (MTD) or the recommended phase 2 dose (RP2D).